Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 8/20 | 0.42 |
| ▸ | CNR2 | P34972 | 7/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21617253 | 1.00 | CNR1 (0.42) | CNR1CNR2NPC1KDM4EALDH1A1 | |
| SCHEMBL23308005 | 0.87 | ALDH1A1 (0.45) | CNR1CNR2NPC1KDM4EALDH1A1 | |
| SCHEMBL31504318 | 0.86 | NPC1 (0.45) | CNR1CNR2NPC1KDM4EALDH1A1 | |
| SCHEMBL21623472 | 0.86 | NPC1 (0.45) | CNR1CNR2NPC1KDM4EALDH1A1 | |
| SCHEMBL21617254 | 0.84 | FGFR4 (0.38) | CNR2ALDH1A1POLB | |
| SCHEMBL31504370 | 0.84 | CNR2 (0.42) | CNR2ALDH1A1HPGDPOLB | |
| SCHEMBL21617159 | 0.84 | CNR2 (0.42) | CNR2ALDH1A1HPGDPOLB | |
| SCHEMBL21617197 | 0.81 | CTSK (0.40) | CNR2HPGD | |
| SCHEMBL31504434 | 0.81 | CTSK (0.40) | CNR2HPGD | |
| SCHEMBL21617306 | 0.78 | MAOB (0.46) | NPC1KDM4EALDH1A1SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112638877-B | Phenyl/pyridinyl-N-phenyl/pyridinyl derivatives for the treatment of RNA viral infections | ABIVAX公司 | 2025-04-22 | — | — | CN | disclosed |